Kiromic Biopharma Inc KRBP:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
0.45quote price arrow down-0.005 (-1.0989%)
Volume
73,978
52 week range
0.23 - 7.99
Loading...
  • Open0.46
  • Day High0.472
  • Day Low0.44
  • Prev Close0.455
  • 52 Week High7.99
  • 52 Week High Date06/29/21
  • 52 Week Low0.23
  • 52 Week Low Date05/24/22

Key Stats

  • Market Cap7.05M
  • Shares Out15.67M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-71.24

KEY STATS

  • Open0.46
  • Day High0.472
  • Day Low0.44
  • Prev Close0.455
  • 52 Week High7.99
  • 52 Week High Date06/29/21
  • 52 Week Low0.23
  • 52 Week Low Date05/24/22
  • Market Cap7.05M
  • Shares Out15.67M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-71.24

RATIOS/PROFITABILITY

  • EPS (TTM)-2.30
  • P/E (TTM)-0.20
  • Fwd P/E (NTM)-0.26
  • EBITDA (TTM)-24.834M
  • ROE (TTM)-133.45%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)1.66%

EVENTS

  • Earnings Date08/11/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kiromic Biopharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Kiromic BioPharma, Inc. is a preclinical stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing immuno-oncology applications through its product pipeline. It is developing a range of product candidates for the treatment of blood cancers and solid tumors. Its lead product candidates include ALEXIS-PRO-1 and ALEXIS-ISO-1. The Company is developing its brand of chimeric antigen receptor (CAR) T cell product candidates known as...
Address
7707 Fannin St., Suite 140
Houston, TX
77054
United States